Trevena, Inc. (TRVN) Financials

TRVN Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 19.2 million 42.5 million
June 30, 2024 22.9 million 41.9 million
March 31, 2024 31.1 million 45.8 million
Dec. 31, 2023 40.6 million 48.3 million

TRVN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -4.5 million 556000
June 30, 2024 -7.2 million 588000
March 31, 2024 -9.4 million 681000
Dec. 31, 2023 -6.0 million 733000

TRVN Net Income

No data available :(

TRVN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 13.5 million 35.6 million 4.7 million
June 30, 2024 16.4 million 35.4 million 4.9 million
March 31, 2024 23.6 million 35.5 million 5.2 million
Dec. 31, 2023 33.0 million 35.2 million 4.4 million

TRVN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 852801
June 30, 2024 852722
March 31, 2024 21.3 million
Dec. 31, 2023 691564

TRVN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - 1.9 million 3.9 million -
June 30, 2024 - 3.1 million 3.5 million -
March 31, 2024 21000 4.0 million 5.8 million -
Dec. 31, 2023 21000 4.2 million 4.4 million -

TRVN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 283000 114000
June 30, 2024 325000 192000
March 31, 2024 20000 176000
Dec. 31, 2023 -81000 1.5 million

TRVN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TRVN

Price: $0.01

52 week price:
0.00
1.93

Earnings Per Share: -48.89 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 42100

Ebitda: -15.1 million

Market Capitalization: 1728

Links: